Showing results (341-350 of 418) with videos related to
Sort By:
Pageof 42
Clinical Transplantation|December 12, 2001
Pharmacokinetics help optimizing mycophenolate mofetil dosing in kidney transplant patientsD Cattaneo, F Gaspari, S Ferrari, et al.Thrombosis and Haemostasis|October 1, 1991
Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasmaE M Faioni, F Franchi, A Krachmalnicoff, et al.American Journal of Nephrology|January 1, 1985
Inhibition of human platelet aggregation by parathyroid hormone. Is cyclic AMP implicated?A Benigni, M Livio, P Dodesini, et al.Transplantation|July 1, 1992
Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantationN Perico, P Ruggenenti, F Gaspari, et al.Blood|August 15, 1997
Fluid shear stress modulates von Willebrand factor release from human vascular endotheliumM Galbusera, C Zoja, R Donadelli, et al.Journal of the American Society of Nephrology : JASN|August 11, 1998
Progressive glomerular injury in the MWF rat is predicted by inborn nephron deficitA Fassi, F Sangalli, R Maffi, et al.Kidney International|October 24, 2000
Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN GroupP Ruggenenti, A Perna, M Lesti, et al.The Journal of Clinical Investigation|June 13, 1998
Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashionM Morigi, S Angioletti, B Imberti, et al.Clinical Nephrology|May 1, 1987
Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology GroupS Pasquali, P Zucchelli, S Casanova, et al.Kidney International|July 28, 2001
Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritisC Zoja, A Benigni, M Noris, et al.Pageof 42